Skip to main content
FinSpry Logo
FinSpry
CNTA logo
CNTA
(NASDAQ)
Centessa Pharmaceuticals plc
$39.75-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Centessa Pharmaceuticals plc (CNTA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Centessa Pharmaceuticals plc stock.

Analyst Consensus Rating

Investment consensus from 9 professional research analysts

Consensus Rating

Hold
Based on 9 unique analysts
(10 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$43.50
↑ 9.43% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CNTA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Benjamin Burnett
Wells Fargo
HoldDowngrades
$35.00 → $42.00
Debjit Chattopadhyay
Guggenheim
HoldDowngrades
-
Google Biotechnology
TipRanks - Google
BuyDowngrades
$25.00 → $44.00
OpenAI Biotechnology
TipRanks - OpenAI
HoldReiterates
$22.00 → $43.00
David Risinger
Leerink Partners
HoldDowngrades
$36.00 → $40.00
Sudan Loganathan
Stephens
HoldUpgrades
$35.00 → $47.00
Rudy Li
Wolfe Research
HoldDowngrades
-
Mayank Mamtani
B Riley
HoldUpgrades
$45.00
Ami Fadia
Needham
HoldDowngrades
-
Rudy Li
Wolfe Research
BuyInitiates
$40.00

Frequently Asked Questions

What is the analyst consensus rating for CNTA?

The analyst consensus rating for CNTA is "Hold" based on 9 analyst recommendations.

What is the average price target for CNTA?

The average 12-month price target for CNTA is $43.50, representing an upside of 9.4% from the current price of $39.75.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.